Company Filing History:
Years Active: 1999-2009
Title: Gernot Langer: Innovator in Medicinal Chemistry
Introduction
Gernot Langer is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel therapeutic agents. With a total of five patents to his name, Langer's work focuses on addressing critical health issues.
Latest Patents
One of Langer's latest patents is for "9-chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments." This invention relates to 9-chloroprostaglandin derivatives that may be advantageous for the treatment of fertility problems. Another notable patent is "In Vitro screening for ligands of the estrogen receptor." This method describes a process for screening test substances for ligands using two assay systems, which can be beneficial in treating and preventing neuro-degeneration in the cerebral cortex, particularly for age-related cognitive disorders and Alzheimer's disease.
Career Highlights
Gernot Langer is associated with Schering Aktiengesellschaft, a company known for its focus on pharmaceuticals and healthcare. His innovative work has positioned him as a key figure in the development of new medicinal compounds. Langer's patents reflect his commitment to advancing medical science and improving patient outcomes.
Collaborations
Throughout his career, Langer has collaborated with notable colleagues such as Andreas Steinmeyer and Gerald
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.